Mallinckrodt Will Present Data for Investigational, Approved ER Opioid Combo Medicines
August 28, 2014 at 09:01 AM EDT
Mallinckrodt (NYSE: MNK) today announced that clinical data for its investigational opioid, MNK-155 (hydrocodone bitartrate and ...
